TWM632571U - Lozenges with long-lasting absorption function structure - Google Patents

Abstract

The invention relates to a lozenge with a long-acting absorption structure, including a long-acting core and an immediate-release outer layer, wherein the immediate-release outer layer surrounds the long-acting core and has at least a collapsible component. In another embodiment, the immediate release outer layer is adjacent to the long-lasting core and adheres to each other. In another embodiment, the long-acting core or the quick-release outer layer has a rough surface to adjust the time of sustained release and disintegration. In another embodiment, the long-acting core and the quick-release outer layer are aimed at the human digestive system, respectively including different proportions of collagen powder and vitamin C, and are designed with a special structure that can improve the absorption rate of the human digestive system, so that the human body can effectively absorb collagen Protein and vitamin C equivalent ingredients can adjust the time of absorption and release, and avoid unabsorbed drugs remaining in the body to reduce the burden on the human body.

Description

Tablets with long-lasting absorption structure

This creation is about a lozenge with a long-acting absorption structure. It is designed according to the characteristics of the digestive system. The active ingredients are compressed into the long-acting core and the quick-release outer layer in different proportions, and the structure of different designs is used to adjust the absorption and absorption. Release time to increase body absorption rate.

Considering the physical and chemical properties of the drug itself and the need to meet the convenience of taking the drug, many different oral dosage forms have been developed, such as: lozenges, capsules, oral liquids, etc. Among them, directly making lozenges is the most common, and the production process is relatively easy. The excipients and active ingredients are directly compressed into lozenges, and then directly taken orally. Generally, there are lozenges, chewable tablets, film-coated tablets, oral dissolving tablets, sublingual tablets and capsules.

After the lozenge enters the human body, it is decomposed by human organs, and then absorbed nutrients through digestion, so that the active ingredients can achieve their effects. The main organ of the human body responsible for absorbing nutrients is the intestinal tract, while the stomach is responsible for decomposing food. Generally, the operation process of the digestive system is to wait for the stomach to complete the decomposition of food, and then go to the intestinal tract for nutrient absorption; due to the human body’s The digestive system has this characteristic, and there have been previous cases to improve the absorption effect of the drug after entering the human body, so that the main active ingredients of the drug can be protected when they enter the stomach, and are not absorbed until they enter the intestinal tract. However, how to best However, the absorption rate of chemical drugs is always a subject that needs to be broken through.

The release time of the active ingredients of currently commercially available medicines is too short, and the absorption rate of the active ingredients is too low. Therefore, the frequency of consumption has to be increased, and while increasing the frequency of consumption, The amount of the excipient is also relatively increased, so that the concentration of the excipient in the blood is too high, which will burden the body and increase the risk of possible side effects. In addition, all active ingredients are released in a short period of time, and will be destroyed by gastric acid in the stomach environment, and most of them cannot be absorbed by the stomach. After entering the intestinal tract, the active ingredients have already been destroyed by gastric acid and cannot be absorbed by the intestinal tract. Therefore, the absorption rate of effective ingredients in currently marketed medicines and health foods is still insufficient.

The stomach and intestinal tract have different absorption effects for different active ingredient systems. Therefore, although there are many previous cases that have done research on the characteristics of the human digestive system and improved the absorption effect of drugs after entering the human body, there are still many In order to find the best drug absorption rate, it is necessary to cooperate with the different absorption effects of the stomach and intestinal tract for different active ingredients. In particular, the higher the drug absorption rate, the higher the drug efficacy. In addition to being good, it can also reduce the burden on the human body and prevent unabsorbed drugs from remaining in the body.

In view of this, in order to improve the absorption rate of active ingredients in the human body, the author tried tablets with different structures, placed them in an environment that simulated the human digestive system, and after many experiments and modifications, finally designed this creation. Long-acting absorbent lozenges.

In one embodiment, a tablet with an extended-acting absorbent structure includes an extended-acting core and an immediate-release outer layer. The long-wearing core comes in a sheet form. An immediate-release outer layer wraps around a long-lasting core. Wherein, the immediate-release outer layer includes a base component and a collapsible component, and the base component and the collapsible component are mixed and evenly distributed in the immediate-release outer layer.

In one embodiment, the base component accounts for more than 80% by weight of the immediate-release outer layer, and the collapse component accounts for less than 20% by weight of the immediate-release outer layer.

In one embodiment, the long-acting core includes a first active ingredient and a first excipient. The first functional ingredient at least includes the first collagen and the first vitamin C, and the first functional ingredient accounts for 50%-70% by weight of the long-acting core. The first excipient accounts for 30%-50% by weight of the long-acting core.

In one embodiment, the base ingredient includes a second functional ingredient and a second excipient. The second functional component includes the second collagen and the second vitamin C, and the second functional component accounts for 20%-30% by weight of the basic component. The second excipient accounts for 50%-70% by weight of the base component.

In one embodiment, the immediate release outer layer is in the shape of a circular tablet and contains a long-acting core in the shape of a circular tablet. In one embodiment, groove lines are formed on the upper and lower surfaces of the quick-release outer layer, and a first arc surface is formed on the side. In one embodiment, the upper and lower surfaces of the long-lasting core each form a first rough surface, and a second arc surface is formed at a side. In one embodiment, the immediate release outer layer is oval in shape and contains a depot core in oval shape. In one embodiment, the immediate release outer layer is oval in shape and contains a long-acting core in the shape of a circular disc. In one embodiment, the upper and lower surfaces of the long-lasting core each form a first rough surface, and a second arc surface is formed at a side. In one embodiment, the shape of the immediate-release outer layer can be one of triangular, quadrangular, clam-shaped, and hollow circular, or a combination thereof.

In another embodiment, a lozenge with a depot absorbent structure includes a depot core and an immediate release outer layer. The long-lasting core is in the form of a sheet and has a first joint surface. The immediate release outer layer has a second attachment surface, and the immediate release outer layer includes a base component and a disintegrating component. Wherein, the quick-release outer layer is adjacent to the long-acting core, and the second connecting surface is attached to the first connecting surface.

In another embodiment, both the first connecting surface and the second connecting surface are formed by a plurality of arc surfaces, and the plurality of arc surfaces of the first connecting surface are connected with the plurality of arc surfaces of the second connecting surface Correspondingly, the first connection surface and the second connection surface can be closely combined. A plurality of curved surfaces are designed on the first connecting surface and the second connecting surface to increase the connecting area and enhance the strength of the connection. In this way, the plurality of curved surfaces can be adjusted according to requirements during actual manufacturing.

In another embodiment, the lozenge with long-lasting absorption function structure further includes an outer packaging body. Wherein, the outer packaging body includes a main body and a plurality of covering films. The main body has a plurality of accommodating spaces, and each accommodating space is filled with a lozenge with a long-lasting absorption function structure. Each cover film is pasted and covered on each accommodating space of the main body. Each cover film has a convex part, but the convex part is not attached to the main body. When the cover film is removed, the structure with long-lasting absorption function can be easily taken out lozenges.

In another embodiment, the material of the outer package is one of aluminum foil, polypropylene (PE), oriented polypropylene (Oriented polypropylene), or a combination thereof.

The purpose of this creation is to provide a lozenge with a long-lasting absorption structure. According to the different characteristics of the stomach and intestinal tract, a special structure that can improve the absorption rate of the human digestive system is designed, and the active ingredients are suppressed in different proportions. The long-acting core and quick-release outer layer allow the human body to effectively absorb collagen and vitamin C equivalent ingredients, and avoid unabsorbed drugs remaining in the body to reduce the burden on the human body.

In order to achieve the purpose of this creation, the creator of this case proposed a lozenge with a long-lasting absorption function structure of an embodiment, the shape of the quick-release outer layer of the described embodiment is a circular sheet, and the surrounded long-acting core has a shape of The disc shape is different from other embodiments in that groove lines are formed on the upper and lower surfaces of the quick-release outer layer, and a first arc surface is formed on the side, so that the user can smoothly release the product along the groove line. The lozenge with long-lasting absorbent structure is peeled in half; the In addition, the upper and lower surfaces of the long-acting core respectively form a first rough surface, and form a second curved surface on the side, so that when the lozenge with long-lasting absorption function structure enters the intestinal tract, the first rough surface can increase The area of action shortens the time of sustained release. Therefore, in this embodiment, the first rough surface with different roughness can be designed according to the requirement of sustained release time.

In order to achieve the purpose of this creation, the creator of this case proposed a lozenge with a long-lasting absorption function structure of an embodiment. In this embodiment, when making the lozenge with a long-term absorption function structure of this creation, you can first The long-acting core is made hollow, and the quick-release outer layer surrounds the long-acting core, which is also hollow, so that the hollow lozenge with a long-lasting absorption structure is similar to the traditional food toy: Beep sugar; so, when When the user takes the hollow lozenge with a long-lasting absorption structure, the user can play a special tone at the same time, increasing the pleasure of taking it.

In order to achieve the purpose of this creation, the creator of this case proposed a lozenge with a long-lasting absorption function structure according to an embodiment. The embodiment provides three implementation forms. In the three implementation forms, the shape of the immediate-release outer layer is different. It is elliptical, and the difference is the form of the long-acting core, wherein, in the first implementation form, the shape of the quick-release outer layer is elliptical, and contains the long-acting core in the shape of a circular sheet; the second In the embodiment, the immediate-release outer layer is oval in shape and contains a long-acting core in the shape of an ellipse; and in the third embodiment, the immediate-release outer layer is in the shape of an ellipse and contains a circular tablet in the shape. Shaped long-acting core, and the upper and lower surfaces of the long-lasting core respectively form a first rough surface, and form a second curved surface on the side, so that when the lozenge with long-lasting absorption function structure enters the intestinal tract, the first The rough surface can increase the area of action and shorten the time of sustained release. Therefore, in this embodiment, the first rough surface with different roughness can also be designed according to the requirements of the sustained release time.

Additionally, particularly, in other embodiments, the shape of the immediate release outer layer can be Made into triangle, quadrangle, or clam shape, the lozenge with long-lasting absorption function structure can have various shapes.

In order to achieve the purpose of this creation, the creator of this case proposed an embodiment of a lozenge with long-lasting absorption function structure. The first rough surface and the second rough surface are formed under the quick-release outer layer, wherein the purpose of adding the first rough surface and the second rough surface is to increase the active area. Therefore, according to requirements, the first rough surface and the second rough surface with different roughness can be designed to control different sustained release times and disintegration times.

1: Tablets with long-lasting absorption structure

10: long-term core

101: first rough surface

102: Second arc surface

103: The first connecting surface

11: quick release outer layer

11a: Triangle

11b: quadrangular

11c: clam shape

111: Groove line

112: The first arc surface

113: The second connecting surface

114: second rough surface

2: Outer packaging

20: subject

201:Accommodating space

21: cover sheet

211: convex part

[Fig. 1] is a three-dimensional partial sectional view of the lozenge with long-lasting absorption function structure of the first embodiment of the present invention.

[Fig. 2] is a partial three-dimensional cross-sectional view of a lozenge with a long-lasting absorption function structure according to the second embodiment of the present invention.

[Fig. 3] is a three-dimensional view of the lozenge with long-acting absorption function structure of the second embodiment of the present invention.

[ Fig. 4 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the third embodiment of the present invention.

[Fig. 5] is a three-dimensional partial sectional view of a lozenge with a long-lasting absorption function structure according to the third embodiment of the present invention.

[ Fig. 6 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the fourth embodiment of the present invention.

[ Fig. 7 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the fourth embodiment of the present invention.

[ Fig. 8 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the fourth embodiment of the present invention.

[Fig. 9] is a three-dimensional view of the triangular lozenge with long-lasting absorption function structure of the invention.

[Fig. 10] is a three-dimensional view of the quadrangular lozenge with long-lasting absorption function structure of the present invention.

[Fig. 11] is a three-dimensional view of the clam-shaped lozenge with long-lasting absorption function structure of this invention.

[ Fig. 12 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the fifth embodiment of the present invention.

[ Fig. 13 ] is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the sixth embodiment of the present invention.

[Fig. 14] is a schematic front view of the packaging structure of the tablet with the long-lasting absorption function structure of the present invention.

[Fig. 15] is a side sectional view of the packaging structure of the lozenge with the long-lasting absorption function structure of the present invention.

[Fig. 16] is a side sectional view of the packaging structure of the lozenge with the long-lasting absorption function structure of the present invention.

In order to more clearly describe the lozenge with long-lasting absorption function proposed by this creation, the following will describe the preferred embodiment of this creation in detail in conjunction with the drawings.

First of all, the first embodiment of this creation is introduced first. Please refer to FIG. 1, which is a three-dimensional partial sectional view of the lozenge with long-lasting absorption function structure of the first embodiment of this creation. Figure 1 As shown, the lozenge 1 with long-acting absorption function structure of the present creation includes a long-acting core 10 and an immediate-release outer layer 11, and the long-acting core 10 is homogeneous and circular. The immediate release outer layer 11 is homogeneous and in the form of a circular sheet surrounding the long-acting core 10 and having at least a collapsible component. Wherein, the collapsible component accounts for less than 20% by weight of the immediate-release outer layer 11 . The long-acting core 10 further has a first excipient and a first functional ingredient, and the first excipient accounts for 30% to 50% by weight of the long-acting core 10, and the first functional ingredient includes the first collagen and the first Vitamin C and the first functional ingredient account for 50%~70% by weight of the long-acting core 10. The immediate-release outer layer 11 further has a second excipient and a second functional ingredient, the second excipient accounts for 50% to 70% by weight of the immediate-release outer layer 11, and the second functional ingredient includes a second collagen and a second vitamin C, and account for 20% to 30% by weight of the immediate release outer layer 11.

In this creation, the quick-release outer layer 11 is mainly dissolved in the stomach. When the lozenge 1 with a long-lasting absorption structure enters the environment of the stomach, the quick-release outer layer 11 will disintegrate within half an hour, and the quick-release can The second active ingredient absorbed by the stomach. In some embodiments, the content of the second active ingredient in the quick-release outer layer 11 is less than that of the first active ingredient in the long-acting core 10, which can avoid the burden on the body caused by releasing too many active ingredients in a short time.

The long-acting core 10 is mainly dissolved in the intestine. When the tablet 1 with long-acting absorption function enters the intestinal environment from the stomach environment, the first active ingredients in the long-acting core 10 can be released stably6~8 hours, effectively prolonging the release time. In this way, the release of a large amount of active ingredients in a short time can be avoided, and unnecessary side effects and risks can be reduced.

In the embodiment of this creation, the first effective ingredient and the second effective ingredient can be a mixture of collagen powder and vitamin C powder, however, collagen powder and vitamin C powder are only one of the embodiments of this creation, not Used to limit the patent scope of this creation.

Next, the second embodiment of this creation will be introduced. Please refer to FIG. 2, which are partial three-dimensional cross-sectional views of lozenges with a long-lasting absorption function structure according to the second embodiment of this creation. A lozenge 1 with a long-acting absorption structure includes a long-acting core 10 and an immediate-release outer layer 11 . The immediate release outer layer 11 is homogeneous and surrounds the long-acting core 10 . Different from the first embodiment, groove lines 111 are formed on the upper and lower surfaces of the quick-release outer layer 11, and a first arc surface 112 is formed on the side surface. Tablet 1 with long-lasting absorbent structure is simply peeled in half. In addition, first rough surfaces 101 are formed on the upper and lower surfaces of the long-lasting core 10 . In this way, when the eater takes the lozenge 1 with the structure of long-acting absorption function, it enters the oral cavity, and the quick-release outer layer 11 will disintegrate within half an hour, and when the lozenge 1 with the structure of long-acting absorption function enters the After the intestinal tract, the first rough surface 101 can increase the area of action and shorten the time of sustained release. Therefore, in this embodiment, the first rough surface 101 with different roughness can be designed according to the requirements of the sustained release time.

Next, another aspect of the second embodiment of the present invention will be introduced. Please refer to FIG. 3 , which is a three-dimensional view of the lozenge with long-lasting absorption function structure of the second embodiment of the present invention. As shown in Figure 3, the shape of the quick-release outer layer 11 of the second embodiment of the present invention is an olive-shaped sheet, and the shape of the surrounded long-acting core 10 is a circular sheet. Unlike the first embodiment, the quick-release A groove line 111 is formed on the upper and lower surfaces of the outer layer 11, and a first arc surface 112 is formed on the side surface, so that the user can smoothly take the lozenge 1 with long-lasting absorption function structure along the groove line 111 Peel in half.

Please refer to Fig. 4 and Fig. 5, which are respectively the side-view structure sectional view of the lozenge with the long-acting absorption function structure of the third embodiment of the invention, and the lozenge with the long-acting absorption function structure of the third embodiment of the invention The three-dimensional partial section view. As shown in Figure 4 and Figure 5, in the third practice of this creation In the embodiment, when making the lozenge 1 with long-acting absorption function structure of this invention, the long-acting core 10 can be made into a hollow ring first, and then the quick-release outer layer 11 can surround the long-acting core 10, and the same is The hollow ring makes the ring-shaped lozenge 1 with long-lasting absorption function similar to the traditional food toy: Beep candy. In this way, when the user takes the ring-shaped lozenge 1 with a long-lasting absorption function structure of the present creation, he can play a special tone at the same time, which increases the pleasure of taking it.

Please refer to Fig. 6 to Fig. 8, which are the side view structural sectional views of the lozenge with long-acting absorption function structure of the fourth embodiment of the invention; Among them, the cross-sectional shapes of the quick-release outer layer 11 are all elliptical, and the difference is the shape of the long-acting core 10 . Wherein, in FIG. 6 , the immediate-release outer layer 11 is oval in shape and contains a long-acting core 10 in the shape of a sheet. In Fig. 7, the immediate release outer layer 11 is oval in shape and contains a long-acting core 10 in oval shape. And the shape of the quick-release outer layer 11 in Fig. 8 is ellipse, and contains the long-acting core 10 that is shaped as a circular sheet, and the upper and lower surfaces of the long-lasting core 10 respectively form a first rough surface 101, and A second arc surface 102 is formed on the side. In this way, similarly, when the lozenge 1 with a long-lasting absorption function structure enters the intestinal tract, the first rough surface 101 can increase the area of action and shorten the time of sustained release. Therefore, in the fourth embodiment, it can also be used according to The first rough surface 101 with different roughness levels is designed according to the requirement of the sustained release time.

Please refer to Figures 9 to 11, which are three-dimensional views of the triangular, quadrangular, and clam-shaped lozenges with long-lasting absorption function structures. As shown in Figures 9 to 11, the shape of the immediate-release outer layer can be made into a triangle 11a, a square 11b, or a clam 11c, so that the tablet 1 with a long-lasting absorption structure can have various shapes.

Next, please refer to FIG. 12 , which is a cross-sectional side view of the lozenge with a long-lasting absorption function structure according to the fifth embodiment of the present invention. As shown in Figure 12, the tool of the fifth embodiment of the present invention The lozenge 1 with long-acting absorption function structure includes a long-acting core 10 and an immediate-release outer layer 11 . The long-lasting core 10 is homogeneous and sheet-shaped, and has a first connection surface 103 . The immediate release outer layer 11 has a second connecting surface 113 and at least has a collapsible component. Wherein, the quick-release outer layer 11 is disposed under the long-acting core 10 , and the second connecting surface 113 is attached to the first connecting surface 103 . In some embodiments, both the first connecting surface 103 and the second connecting surface 113 are formed by a plurality of arc surfaces, and the plurality of arc surfaces of the first connecting surface 103 are the same as the plurality of arc surfaces of the second connecting surface 113 Correspondingly, the bonding area between the first connecting surface 103 and the second connecting surface 113 is greatly increased, and the bonding force thereof is strengthened.

In the fifth embodiment of the present invention, the first connection surface 103 and the second connection surface 113 are designed with a plurality of curved surfaces in order to increase the connection area and improve the strength of the connection. In this way, the actual manufacturing can be adjusted according to the requirements. Multiple curved surfaces, or other shapes that can increase the area.

Continuing from the above, the long-acting core 10 further has a first excipient and a first functional ingredient, and the first excipient accounts for 30%-50% by weight of the long-acting core 10, and the first functional ingredient includes the first collagen And the first vitamin C, and account for 50%~70% by weight of the long-acting core 10. The quick-release outer layer 11 further has a second excipient and a second functional ingredient, and the second excipient accounts for 50% to 70% by weight of the immediate-release outer layer 11, and the second functional ingredient includes the second collagen and the second functional ingredient. Two vitamin C, and account for 20%~30% by weight of the quick-release outer layer 11.

In addition, please refer to FIG. 13 , which is a side view structural cross-sectional view of a lozenge with a long-lasting absorption function structure according to the sixth embodiment of the present invention. As shown in Figure 13, most of the components of the sixth embodiment of the present invention are the same as those of the fifth embodiment, the difference is that a first rough surface 101 is formed above the long-acting core 10, and a second rough surface is formed below the quick-release outer layer 11. Two rough surfaces 114 . Among them, the first The purpose of the first rough surface 101 and the second rough surface 114 is to increase the active area. Therefore, according to requirements, the first rough surface 101 and the second rough surface 114 can be designed with different roughness levels to control different sustained-release times and disintegration times.

Next, we will introduce the packaging method of the tablet with the long-lasting absorption function structure of the present invention, please refer to Fig. 14 to Fig. 16 . Wherein, Fig. 14 is a front view schematic diagram of the packaging structure of the lozenge with the long-acting absorption function structure of the present invention, and Fig. 15 and Fig. 16 are side sectional views of the packaging structure of the lozenge with the long-acting absorption function structure of the present invention. As shown in FIG. 14 , the lozenge 1 with long-lasting absorption structure of the present invention can be accommodated inside the outer packaging body 2 . The outer packaging body 2 includes a main body 20 with a plurality of accommodating spaces 201, and each accommodating space 201 can be filled with a lozenge 1 with a long-lasting absorption structure (not shown in FIG. 14 ). The cover sheet 21 is pasted and covered on the accommodating space 201 of the main body 20 , and has a convex portion 211 , and the convex portion 211 is not pasted on the main body 20 . Wherein, any user can tear the cover sheet 21 from the convex part 211 to take out the lozenge 1 with a long-lasting absorption function structure; in addition, the material of the outer packaging body 2 is aluminum foil, polypropylene (Polypropylene, PE), Or biaxially extended polypropylene (Oriented polypropylene).

Continuing the above, as shown in FIG. 15 , each lozenge 1 with a long-lasting absorption structure is accommodated in the accommodation space 201 of the main body 20, and then sealed by a cover sheet 21 to maintain a long-lasting absorption function. The tablet 1 of the structure can be housed in the housing space 201 in a sealed state. When it needs to be used, it is only necessary to tear off the cover sheet 21 from the convex portion 211, and then the lozenge 1 with long-lasting absorption function structure can be taken out for consumption. In addition, as shown in FIG. 16 , the cover sheet 21 can be squeezed open. Therefore, the outer packaging body 2 provided by the present invention can also be squeezed to take out the lozenge 1 with a long-lasting absorption function structure. It can be seen from this that there are two ways to take out the outer packaging body 2 provided by the invention, including tearing the cover sheet 21, and squeezing the cover sheet 21 from the main body 20 to the accommodating space 201, so that The cover sheet 21 is naturally separated from the main body 20, which is quite convenient.

The author provides a formula for making the lozenge 1 with the structure of long-term absorption function. First, take 25 mg of disintegrated component powder, 150 mg of excipient powder and 75 mg of vitamin C powder and mix evenly, and then compress the lozenge Then, take 100 mg of excipient powder and 150 mg of collagen powder, mix them evenly, and compress them together with the immediate release outer layer to obtain the tablet with long-lasting absorption function structure The tablet 1, in particular, the lozenge 1 with long-acting absorption function structure of the present invention can be used as health food or medicine.

From the above, it can be known that the tablet 1 with long-acting absorption function structure provided by this creation has a special structure that can improve the absorption rate of the human digestive system, and suppresses the active ingredients in different proportions. The different characteristics of the stomach and intestinal tract allow the human body to effectively absorb collagen and vitamin C equivalent components, and avoid unabsorbed drugs remaining in the body to reduce the burden on the human body.

The above detailed description is a specific description of the feasible embodiment of this creation, but this embodiment is not used to limit the patent scope of this creation, and any equivalent implementation or change that does not deviate from the spirit of this creation should be included in this case within the scope of the patent.

1: Tablets with long-lasting absorption structure

10: long-term core

11: quick release outer layer

Claims (18)

A lozenge with a long-acting absorption structure, comprising: a long-acting core, the long-acting core is in the form of a sheet; and an immediate-release outer layer, the immediate-release outer layer covers the long-acting core, wherein the immediate-release outer layer includes a The base component and a collapsible component are mixed and evenly distributed in the immediate release outer layer. The lozenge with long-lasting absorption function structure as described in Claim 1, wherein the basic component is more than 80% by weight of the immediate-release outer layer, and the collapse component promotes less than 20% by weight of the immediate-release outer layer. The lozenge with long-acting absorption function structure as described in Claim 1, wherein the long-acting core includes: a first functional ingredient, the first functional ingredient at least includes a first collagen and a first vitamin C, and The first functional ingredient accounts for 50%-70% by weight of the long-acting core; and a first excipient, the first excipient accounts for 30%-50% by weight of the long-acting core. The lozenge with long-acting absorption function structure as described in claim 1, wherein the basic ingredient includes: a second functional ingredient, the second functional ingredient includes a second collagen and a second vitamin C, and the first Two functional ingredients account for 20%-30% by weight of the base component; and a second excipient, which accounts for 50%-70% by weight of the base component. The lozenge with long-acting absorption function structure as claimed in item 1, wherein the immediate-release outer layer is in the shape of a circular tablet, and contains the long-acting core in the shape of a circular tablet. The lozenge with long-lasting absorption function structure as described in Claim 5, wherein, the upper and lower surfaces of the immediate-release outer layer respectively form a groove line, and form a first arc surface on the side. The lozenge with long-acting absorption function structure as claimed in item 5, wherein, the upper and lower surfaces of the long-acting core each form a first rough surface, and a second curved surface is formed on the side. The lozenge with long-acting absorption function structure according to claim 1, wherein the immediate-release outer layer is oval in shape and contains the long-acting core in oval shape. The lozenge with long-acting absorption function structure according to claim 1, wherein the immediate-release outer layer is oval in shape and contains the long-acting core in the shape of a circular tablet. The lozenge with long-acting absorption function structure as claimed in item 1, wherein, the upper and lower surfaces of the long-acting core respectively form a first rough surface, and a second curved surface is formed on the side. The lozenge with long-lasting absorption function structure as described in Claim 1, wherein the shape of the immediate-release outer layer can be one of triangle, square, clam-shape and hollow circle or a combination thereof. A lozenge with a long-acting absorption structure, comprising: a long-acting core, the long-acting core is sheet-shaped, and has a first connecting surface; and an immediate-release outer layer, has a second connecting surface, the immediate The outer layer includes a base component and a collapsible component, wherein the quick-release outer layer is disposed adjacent to the long-acting core, and the second connecting surface is attached to the first connecting surface. The lozenge with a long-lasting absorption structure as claimed in claim 12, wherein the basic component accounts for more than 80% by weight of the immediate-release outer layer, and the collapse component accounts for less than 20% by weight of the immediate-release outer layer. The lozenge with long-acting absorption function structure as described in claim 12, wherein the long-acting core includes: a first functional ingredient, the first functional ingredient at least includes a first collagen and a first vitamin C, and The first functional ingredient accounts for 50%-70% by weight of the long-acting core; and a first excipient, the first excipient accounts for 30%-50% by weight of the long-acting core. The lozenge with long-acting absorption function structure as described in claim item 12, wherein the basic ingredient includes: a second functional ingredient, the second functional ingredient includes a second collagen and a second vitamin C, and the first Two functional ingredients account for 20%-30% by weight of the base component; and a second excipient, which accounts for 50%-70% by weight of the base component. The lozenge with long-acting absorption function structure as described in claim 12, wherein, the first connecting surface and the second connecting surface are both formed by a plurality of arc surfaces, and the plurality of arcs of the first connecting surface The surfaces correspond to the plurality of arc surfaces of the second connecting surface, so that the first connecting surface and the second connecting surface can be closely combined. The lozenge with long-acting absorption function structure as described in claim 12 further includes an outer packaging body, wherein the outer packaging system includes: A main body has a plurality of accommodation spaces, and each accommodation space is filled with a tablet with a long-lasting absorption function structure; and a plurality of covering films are pasted and covered between the accommodation spaces of the main body Each of the covering films has a protrusion, and the protrusions are not attached to the main body; wherein, when the covering film is removed, the lozenge with long-lasting absorption function structure can be taken out. According to claim 17, the lozenge with a long-lasting absorption function structure, wherein the material of the outer package is one of aluminum foil, polypropylene, biaxially stretched polypropylene or a combination thereof.

Images